Unraveling the many faces of angioimmunoblastic T-cell lymphoma: clinical, pathological, and molecular heterogeneity. [PDF]
Chen JP +8 more
europepmc +1 more source
Prognostic value of early post-treatment 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy [PDF]
Seyed Ali Mirshahvalad +10 more
openalex +1 more source
A novel strategy for in situ multiplexed miRNA analysis of plasma extracellular vesicles (EValarm) has been developed. EValarm enables straightforward detection of different extracellular vesicle miRNAs from plasma samples through systematic screening of liposome surface charges, without requiring complex pretreatment steps, and achieves satisfactory ...
Jing‐Yuan Ma +13 more
wiley +1 more source
Corneal perforation in the setting of NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis. [PDF]
Mark JR, Ma JH.
europepmc +1 more source
Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules [PDF]
HD Foss +7 more
openalex +1 more source
Cell‐Free DNA‐Based Theranostics for Inflammatory Disorders
Summary on the dual potential of cfDNA as biomarkers and therapeutic targets for inflammatory disorders. Figure was created with BioRender.com. ABSTRACT Inflammatory disorders are characterized by immune‐mediated inflammatory cascades that can affect multiple organs.
Jiatong Li +7 more
wiley +1 more source
Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients? [PDF]
Lan Y +13 more
europepmc +1 more source
Regulatory T cells (Tregs) suppress antitumor immunity. This study identifies that the translation scaffold DAP5/eIF4G2 is upregulated in tumor‐infiltrating Tregs (ti‐Tregs). DAP5 mediates an alternate translation mode to sustain CD25 and MCL‐1 expression, which is critical for ti‐Treg stability and survival in the tumor microenvironment.
Xiaojiang Lai +12 more
wiley +1 more source
Ocular manifestations of patients with extranodal NK/T-cell lymphoma. [PDF]
Luo J +7 more
europepmc +1 more source
Targeted Therapy of CAR+ T-Cell Lymphoma after Anti-BCMA CAR T-Cell Therapy
Adolfo Aleman +34 more
openalex +2 more sources

